Patents Issued in September 18, 2007
  • Patent number: 7271111
    Abstract: A shadow mask deposition system includes a plurality of identical shadow masks arranged in a number of stacks to form a like number of compound shadow masks, each of which is disposed in a deposition vacuum vessel along with a material deposition source. Materials from the material deposition sources are deposited on the substrate via openings in corresponding compound shadow masks, each opening being formed by the whole or partial alignment of apertures in the shadow masks forming the compound shadow mask, to form an array of electronic elements on the substrate.
    Type: Grant
    Filed: June 8, 2005
    Date of Patent: September 18, 2007
    Assignee: Advantech Global, Ltd
    Inventor: Thomas P. Brody
  • Patent number: 7271112
    Abstract: Methods of forming conformal films with increased density are described. The methods may be used to improve gap fill in semiconductor device manufacturing by eliminating seams and voids. The methods involve operating at high reactant partial pressure. Additionally, film properties may be further enhanced by optimizing the temperature of the substrate during exposure to the metal-containing and/or silicon-containing precursor gases commonly used in conformal film deposition techniques such as ALD and PDL.
    Type: Grant
    Filed: December 30, 2004
    Date of Patent: September 18, 2007
    Assignee: Novellus Systems, Inc.
    Inventors: George D. Papasouliotis, Raihan M. Tarafdar, Adrianne K. Tipton, Ron Rulkens, Dennis M. Hausmann, Jeff Tobin
  • Patent number: 7271113
    Abstract: The present invention relates to a multilayer product 1 having at least one first layer 2, an absorbent intermediate layer 3 and a second layer 4, whereby at least the first layer 2 contains at least one first material 5 and one second material 6. The first layer 2 and/or the second layer 4 is at least partially liquid permeable. The first material 5 has a higher melting point than the second material 6, with the second material 6 creating a bond to the second layer 4.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: September 18, 2007
    Assignee: Fiberweb Corovin GmbH
    Inventors: Joachim Bauer, Indra Roy
  • Patent number: 7271114
    Abstract: A ceramic powder having a perovskite structure is manufactured by synthesizing a ceramic powder by a dry synthesis process and then heat-treating the synthesized ceramic powder in a solution. The dry synthesis method includes a solid phase synthesis method, an oxalate method, a citric acid method and a gas phase synthesis method.
    Type: Grant
    Filed: March 24, 2004
    Date of Patent: September 18, 2007
    Assignee: Taiyo Yuden Co., Ltd.
    Inventors: Chie Kawamura, Atsushi Tanada, Hirokazu Chazono
  • Patent number: 7271115
    Abstract: A dielectric ceramic composition contains a substance represented by general formula 100(Ba1?xCax)mTiO3+aMnO+bCuO+cROn (wherein the coefficients 100, a, b, and c each represent mols; R represents at least one element selected from the group consisting of Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb and Lu; and n represents a number determined by the valence of the rare-earth element R and is a positive number required for maintaining electroneutrality) and a sintering aid. The dielectric ceramic composition satisfies the relationships 0.990?m?1.050; 0.01?x?0.20; 0.5?a?3.5; 0.1?b?5.0; and 10?c?20, and the amount of the sintering aid represented by d in terms of parts by weight per 100 parts by weight of the compound represented by (Ba1?xCax)mTiO3 satisfies 0.8?d?5.0 Furthermore, VO3/2 may be added to increase the breakdown field.
    Type: Grant
    Filed: January 8, 2007
    Date of Patent: September 18, 2007
    Assignee: Murata Manufacturing Co., Ltd.
    Inventor: Shoichiro Suzuki
  • Patent number: 7271116
    Abstract: The present invention provides a catalyst containing titanium in bonded form, non-crystalline silicon dioxide and at least one crystalline silicate phase which has a zeolite structure, wherein the non-crystalline silicon dioxide is applied to at least one of the crystalline silicate phases which have a zeolite structure and wherein at least one of the crystalline silicate phases which have a zeolite structure contains silicon-carbon bonds with which non-hydrolytically separable organic groups R are bonded to silicon. Furthermore, the present invention provides a process for preparing this catalyst and a process for producing an epoxide from a compound which contains a carbon-carbon double bond (preferably from propene) comprising reacting the compound which contains a carbon-carbon double bond with hydrogen peroxide in the presence of the catalyst according to the invention.
    Type: Grant
    Filed: May 11, 2004
    Date of Patent: September 18, 2007
    Assignee: Bayer MaterialScience AG
    Inventors: Markus Weisbeck, Marie-Therese Heinen, Jörg Schmitt, Gerhard Wegener, Markus Dugal
  • Patent number: 7271117
    Abstract: Noble metal-containing titanium or vanadium zeolite catalysts are prepared by adding a noble metal source to a titanium or vanadium zeolite that contains templating agent used in the preparation of the zeolite, and then removing the templating agent to form the noble metal-containing titanium or vanadium zeolite catalyst. The catalyst is useful in olefin epoxidation with oxygen and hydrogen.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: September 18, 2007
    Assignee: Lyondell Chemical Technology, L.P.
    Inventor: Roger A. Grey
  • Patent number: 7271118
    Abstract: A catalyst system that exhibits a ratio of ethylene saturation to aromatics ring saturation of greater than 3,500. The catalyst system comprises two components and each component comprises a crystalline molecular sieve having a Constraint Index of from about 1 to about 12 and an effective amount of Group VIII metal. The catalyst system finds particular application in ethylbenzene conversion/xylenes isomerization reactions. The catalyst system can be prepared by incorporating the Group VIII metal into the molecular sieves by competitive ion exchange.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: September 18, 2007
    Assignee: ExxonMobil Chemical Patents Inc.
    Inventors: Brenda A. Raich, Robert A. Crane, Christine N. Elia, Teresa A. Jurgens-Kowal, Gary D. Mohr, David L. Stern
  • Patent number: 7271119
    Abstract: Process for preparing an olefin polymerisation catalyst component in the form of particles having a predetermined size range, said process comprising the steps of a) preparing a solution of a complex of a Group 2 metal and an electron donor by reacting a compound of said metal with said electron donor or a precursor thereof in an organic liquid reaction medium; b) adding said solution of said complex to at least one compound of a transition material to produce an emulsion, the dispersed phase of which contains more than 50 mol % of the Group 2 metal in said complex; c) agitating the emulsion, optionally in the presence of an emulsion stabilizer, in order to maintain the droplets of said dispersed phase within the average size range 5 to 200 m; d) solidifying said droplets of the dispersed phase; and e) recovering the solidified particles of the olefin polymerisation catalyst component, wherein a turbulence minimizing agent (TMA) is added to the reaction mixture before solidifying said droplets of the disperse
    Type: Grant
    Filed: June 18, 2002
    Date of Patent: September 18, 2007
    Assignee: Borealis Technology Oy
    Inventors: Peter Denifl, Timo Leinonen
  • Patent number: 7271120
    Abstract: A catalyst for the preparation of dimethyl carbonate from urea and methanol having a composition on weight base of: active component of from 20 to 50 wt %, and carrier of from 80 to 50 wt %, and prepared by equal-volume spraying and impregnating method is disclosed. The method for the synthesis of dimethyl carbonate can be carried out in a catalytic rectification reactor, said method comprising: (1) dissolving urea in methanol to form a methanol solution of urea; and (2) feeding the methanol solution of urea and methanol counter-currently into the reaction zone, wherein the reaction is carried out at conditions including reaction temperature of from 120° C. to 250° C., reaction pressure of from 0.1 MPa to 5 MPa, kettle bottom temperature of from 70° C. to 210° C., stripping section temperature of from 70° C. to 250° C., rectifying section temperature of from 70° C. to 280° C., and reflux ratio of from 1:1 to 20:1.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: September 18, 2007
    Assignees: Institute of Coal Chemistry, Chinese Academy of Sciences, Feicheng Acid Chemicals Co., Ltd.
    Inventors: Yuhan Sun, Wei Wei, Ning Zhao, Baoyuan Sun, Bingsheng Zhang, Yanjun Chen
  • Patent number: 7271121
    Abstract: Methods for making ?-diimine metal complexes are described. The methods comprise forming an ?-diimine metal complex imine bond in the presence of a metal salt or an ?-acylimine metal complex. The method is particularly using for the production of ?-diimine metal complexes having two different ?-diimine nitrogen groups. The ?-diimine metal complexes are useful for polymerizing or oligomerizing olefins.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: September 18, 2007
    Assignee: Chevron Phillips Chemical Company LP
    Inventors: Brooke L. Small, Michael Carney
  • Patent number: 7271122
    Abstract: The present invention concerns a catalyst for the production of high density polyethylene, by homopolymerising ethylene or copolymerising ethylene and an alpha-olefinic comonomer comprising 3 to 10 carbon atoms, prepared by the steps of: a) selecting a silica support with a specific surface area larger than 300 m2/g; b) treating the silica support with a titanium compound, in order to introduce titanium into the support, or with an aluminium compound, in order to introduce aluminium into the support; c) either treating the titanated silica support with an aluminum compound, in order to introduce aluminum into the titanated silica support, or treating the aluminated silica support with a titanium compound, in order to introduce titanium into the aluminated silica support; d) depositing a chromium compound on the titanated and aluminated silica support to form a catalyst; e) activating the catalyst of step d) under air in a fluidised bed at a temperature of from 600 to 800° C.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: September 18, 2007
    Assignee: Total Petrochemicals Research Feluy
    Inventors: Philippe Bodart, Nicodeme Lonfils, Guy Debras
  • Patent number: 7271123
    Abstract: The invention relates to a molecular sieve catalyst composition, to a method of making or forming the molecular sieve catalyst composition, and to a conversion process using the catalyst composition. In particular, the invention is directed to a molecular sieve catalyst composition of a molecular sieve, a binder and a matrix material, wherein the weight ratio of the binder to the molecular sieve is controlled to provide an improved attrition resistant catalyst composition, particularly useful in a conversion process for producing olefin(s), preferably ethylene and/or propylene, from a feedstock, preferably an oxygenate containing feedstock.
    Type: Grant
    Filed: June 24, 2002
    Date of Patent: September 18, 2007
    Assignee: ExxonMobil Chemical Patents Inc.
    Inventors: Yun-feng Chang, Stephen N. Vaughn, Luc R. M. Martens, Kenneth R. Clem
  • Patent number: 7271124
    Abstract: A process to produce ethylene polymers is provided.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: September 18, 2007
    Assignee: Phillips Petroleum Company
    Inventors: Max P. McDaniel, Elizabeth A. Benham, Al R. Wolfe
  • Patent number: 7271125
    Abstract: A coated metal substrate useful for carrying an exhaust emission treatment catalyst such as a three-way conversion catalyst for use with small engine platforms. The coated metal substrate comprises a metal such as a stainless steel, a carbon steel, a FeCr alloy, HASTELLOY® and the like. The coating on the metal substrate comprises an alumina silicate having alumina particles impregnated therein. The coating is applied using a liquid dispersion containing an aluminum silicate and the alumina particles are dispersed into the aluminum silicate coating while the coating is still wet. The coated metal substrate is then calcined. Thereafter, a washcoat containing an engine exhaust treatment catalyst may be applied to the surface of the coated metal substrate.
    Type: Grant
    Filed: January 14, 2004
    Date of Patent: September 18, 2007
    Assignee: Engelhard Corporation
    Inventors: Michael Patrick Galligan, Young Gin Kim
  • Patent number: 7271126
    Abstract: A method for producing a catalyst for use in the dehydrogenation of ethylbenzene to styrene is disclosed. The catalyst of the present invention comprises a high purity metal and at least one promoter in the form of solid oxides, oxide hydrates, hydroxides, hydroxycarbonates or metals. The catalyst is prepared via a method which comprises the preparation of at least one high purity iron precursor with or without an additional support material and which uses a nominal amount of water in the catalyst production. The catalyst pellets prepared with the high purity metal precursor are essentially free of sulfur and chloride contaminants.
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: September 18, 2007
    Assignee: Sud-Chemie Inc.
    Inventors: Dennis J. Smith, Robert J. O'Brien, X. D. Hu
  • Patent number: 7271127
    Abstract: Disclosed is a catalyst for a partial oxidation reforming reaction of fuel in the form of disk having through-hole. In addition, according to the invention, there is provided a fuel reforming apparatus and method using the catalyst. The catalyst for a partial oxidation reforming reaction of fuel according to the invention makes it possible to progress the partial oxidation reforming reaction of fuel smoothly, to improve the efficiency when reforming the fuel and to simplify the fuel reforming reactor. According to the fuel reforming apparatus and method, since the heat of reaction is efficiently controlled and used, a simple on-off operation, reduction of starting time and a stable operational condition are accomplished, which are indispensably required for a fuel reforming system in fuel cells, such as household, portable and car fuel cells.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: September 18, 2007
    Assignee: Korea Institute of Science and Technology
    Inventors: Suk-Woo Nam, Sang Jun Kong, Seong-Ahn Hong, In-Hwan Oh, Tae-Hoon Lim, Heung Yong Ha, Sung Pil Yoon, Jonghee Han, EunAe Cho
  • Patent number: 7271128
    Abstract: Compositions for increasing valuable agronomic traits in plants are provided comprised of seaweed extract and fish hydrolysate. Methods of preparing compositions of the invention are provided which comprise mixing seaweed extract with fish hydrolysate and fermenting the mixture. Methods of increasing at least one valuable agronomic trait in a plant are provided comprising applying a composition comprising seaweed extract and fish hydrolysate to the plant.
    Type: Grant
    Filed: October 22, 2003
    Date of Patent: September 18, 2007
    Assignee: Iceland BioEnhancers, LLC
    Inventor: Kalidas Shetty
  • Patent number: 7271129
    Abstract: This invention concerns the creation of compounds destined for agricultural use, characterized by butyric amino acids and caprylic amino acids, either salified or not with zinc and copper salts, which, administered in small doses per hectare, have been proven to lead to an increase in crop yield and quality.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: September 18, 2007
    Inventors: Jean Morelle, Eliane Lauzanne, Christophe De Mil
  • Patent number: 7271130
    Abstract: Fungicidal compounds of the general formula (1) wherein X, Y, Z, R1, R2, R3, R4 and R5 have the definitions given in claim 1
    Type: Grant
    Filed: November 10, 2003
    Date of Patent: September 18, 2007
    Assignee: Syngenta Limited
    Inventors: Roger Salmon, David William Langton
  • Patent number: 7271131
    Abstract: An oil-based drilling fluid having a polymer latex capable of providing a deformable latex film on at least a portion of a subterranean sand formation has been discovered to inhibit or control fluid loss and act as a sealing agent when used to drill in sand formations for hydrocarbon recovery operations. Typically, the polymer latex is an aqueous suspension of particles formed by emulsion polymerization that is in turn emulsified into a hydrocarbon base fluid. The polymer particles of suitable size precipitate onto the pores of a subterranean sand formation to at least partial seal the formation with a deformable polymer film.
    Type: Grant
    Filed: September 5, 2003
    Date of Patent: September 18, 2007
    Assignee: Baker Hughes Incorporated
    Inventors: William S. Halliday, David Schwertner, Tao Xiang, Dennis K. Clapper
  • Patent number: 7271132
    Abstract: A superior powder form of a metallic soap for enhancing the properties of an invert emulsion drilling fluid may be prepared by a dry process saponification reaction. The process includes mixing a source of metal cations with the product of a Diels-Alder reaction of dienophiles with fatty acids and/or resin acids and allowing the mixture to react. Heating the mixture increases the rate of reaction. The solid product is ground to form a powder. The properties of the drilling fluid that may be improved by adding the soap include filtration control, fluid loss control, emulsification and emulsion stability, and electrical stability.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: September 18, 2007
    Assignee: Halliburton Energy Services, Inc.
    Inventor: Jeffrey J. Miller
  • Patent number: 7271133
    Abstract: Methods for treating subterranean formations and aqueous treating fluid compositions are provided. The aqueous treating fluid compositions comprise water, a water soluble hydrophobically modified gelling agent polymer produced by grafting a low concentration of hydrophobic monomers thereon, and a low concentration of an ionic surfactant the hydrophobic chain portion of which is associated with the hydrophobic monomers grafted onto the gelling agent polymer resulting in gelling agent polymer molecules having increased radiuses of gyration.
    Type: Grant
    Filed: September 24, 2003
    Date of Patent: September 18, 2007
    Assignee: Halliburton Energy Services, Inc.
    Inventors: Jimmie D. Weaver, Billy F. Slabaugn
  • Patent number: 7271134
    Abstract: Disclosed are methods comprising providing an aqueous polymer dispersion comprising water, an anionic salt, a water-based friction reducing polymer, a polyol, an anionic surfactant, and a nonionic surfactant; mixing the aqueous polymer dispersion with additional water to form an aqueous treatment fluid; and introducing the aqueous treatment fluid into a subterranean formation. Also disclosed are methods comprising providing an aqueous treatment fluid comprising water, an anionic salt, a water-based friction reducing polymer in an amount sufficient to provide friction reduction without forming a gel, a polyol, an anionic surfactant, and a nonionic surfactant; and introducing the aqueous treatment fluid into a subterranean formation.
    Type: Grant
    Filed: December 13, 2005
    Date of Patent: September 18, 2007
    Assignee: Halliburton Energy Services, Inc.
    Inventors: Karen L. King, David E. McMechan, Jiten Chatterji
  • Patent number: 7271135
    Abstract: A rolling bearing, for application in electric auxiliaries for a car, durable owing to high resistance to high temperatures and capable of restraining noises from being generated at low temperatures; and lubricant grease, for low and high temperature application, which can be sealed in the rolling bearing. The lubricant grease includes 100 parts by weight of a mixture of fluorine-containing lubricant grease containing perfluoropolyether oil as a base oil thereof and fluorocarbon resin powder as a thickening agent thereof and urea-containing lubricant grease containing polyester oil as a base oil thereof and a urea compound as a thickening agent thereof; and 3 to 30 parts by weight of polyolefin oil added to the mixed grease. The polyolefin oil has a pour point of not more than ?50° C. and a kinematic viscosity of 10 to 70 mm2/s at 40° C.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: September 18, 2007
    Assignee: NTN Corporation
    Inventors: Mitsunari Asao, Masaki Egami
  • Patent number: 7271136
    Abstract: A cleaning composition based on an aqueous or non-petroleum solvent, and useful for cleaning exterior surfaces such as aircraft exterior surfaces and other metal, glass, rubber and polymer surfaces possesses solvent-like properties with respect to greasy soils; inhibits corrosion and degradation of rubber; is bio-degradable; forms a stable emulsion with water; remains optically clear and stable at multiple dilutions with water; and conforms to MIL-PRF 87937D. The composition includes at least one fatty acid methyl ester, at least one ethoxylated alcohol having an HLB ranging from about 10 to about 14, at least one alkyl polyglycoside having an HLB ranging from about 10 to about 14, at least one hydrotrope, an alkali metal silicate, at least one corrosion inhibitor in an amount effective to prevent corrosion on metals, and water.
    Type: Grant
    Filed: January 3, 2006
    Date of Patent: September 18, 2007
    Assignee: Spray Nine Corporation
    Inventor: Claudia E. Britton
  • Patent number: 7271137
    Abstract: Aqueous decontamination formulations that neutralize biological pathogens for disinfection and sterilization applications. Examples of suitable applications include disinfection of food processing equipment, disinfection of areas containing livestock, mold remediation, sterilization of medical instruments and direct disinfection of food surfaces, such as beef carcasses. The formulations include at least one reactive compound, bleaching activator, inorganic base, and water. The formulations can be packaged as a two-part kit system, and can have a pH value in the range of 7-8.
    Type: Grant
    Filed: January 27, 2004
    Date of Patent: September 18, 2007
    Assignee: Sandia Corporation
    Inventors: Mark D. Tucker, Daniel E. Engler
  • Patent number: 7271138
    Abstract: Through-the-wash automatic dishwashing detergent compositions, especially detergent compositions comprising zinc-containing materials, are provided for protecting glassware from surface corrosion during automatic dishwashing.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: September 18, 2007
    Assignee: The Procter & Gamble Company
    Inventors: Brian Xiaoqing Song, Patricia Sara Berger, James Robert Schwartz, Robert William Corkery
  • Patent number: 7271139
    Abstract: The inventors have isolated novel lipolytic enzyme genes with a high homology to the T. lanuginosus lipase gene and thus well suited for use in gene shuffling. Accordingly, the invention provides a method of generating genetic diversity into lipolytic enzymes by family shuffling of two or more homologous genes which encode lipolytic enzymes. The DNA shuffling technique is used to create a library of shuffled genes, and this is expressed in a suitable expression system and the expressed proteins are screened for lipolytic enzyme activity. The invention also provides a polynucleotide comprising a nucleotide sequence encoding a lipolytic enzyme and a lipolytic enzyme (a polypeptide with lipolytic enzyme activity).
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: September 18, 2007
    Assignee: Novozymes A/S
    Inventors: Noriko Tsutsumi, Jesper Vind, Shamkant Anant Patkar
  • Patent number: 7271140
    Abstract: A stain removing composition having a mixture of N-methyl pyrrolidinone and at least one solvent from the group consisting of 3-pentanol, dipropylene glycol monomethyl ether, propylene glycol n-propyl ether, and diethylene glycol monobutyl ether. Preferably, the stain removing composition comprises, in percent by weight about 70-90%, N-methyl pyrrolidinone and about 10-30%, in percent by weight, at least one of the solvents from the group described above.
    Type: Grant
    Filed: September 8, 2004
    Date of Patent: September 18, 2007
    Assignee: Harris Research, Inc.
    Inventor: Edward E. Durrant
  • Patent number: 7271141
    Abstract: An aqueous liquid composition having a water content of between 20 and 50 wt. %, comprising at least one polyphosphate builder material, potassium ions and sodium ions, wherein the molar ratio of potassium to sodium is between 0.55:1 and 20:1.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: September 18, 2007
    Assignee: Reckitt Benckiser N.V. & Reckitt Benckiser (UK) Limited
    Inventors: Roger Kaiser, Ralf Wiedemann, Marcus Guzmann
  • Patent number: 7271142
    Abstract: A particulate composition comprising particles which consist of a shell wall surrounding a hydrophilic core, wherein the shell wall is formed from a polymeric coacervate and wherein the particles comprise a polymeric amphipathic stabiliser. Also claimed is a process of producing a particulate composition comprising particles which consist of a shell wall surrounding a hydrophilic core, comprising the steps of a) forming an aqueous liquid that contains a wall building material that is capable of forming the shell wall by coacervation, b) dispersing the aqueous liquid into a water immiscible liquid, which comprises a stabilising substance to form a dispersion that comprises aqueous droplets dispersed in a continuous phase of water immiscible liquid, c) subjecting the dispersion to coacervation conditions, such that the wall building material coacervates at the surface of the aqueous doplets, characterised in that the stabilising substance comprises a polymeric amphipathic stabiliser.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: September 18, 2007
    Assignee: Ciba Specialty Chemicals Water Treatments Ltd
    Inventors: Kishor Kumar Mistry, Bryan David Grey
  • Patent number: 7271143
    Abstract: Compositions of the polypeptide SEQ ID NO:1, SEQ ID NO:2, anti-LRP antibodies, LRP antagonists, and/or one or more fibrinolytic agents are formulated for enhancing the fibrinolytic activity, reducing the side effects due to vasoactivity caused by the fibrinolytic agents, and/or prolonging the half lives of the fibrinolytic agents. The invention further relates to combination compositions and/or therapy regimens, comprising the polypeptide SEQ ID NO:1 and/or SEQ ID NO:2 and one or more currently used plasminogen activators.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: September 18, 2007
    Assignee: Thrombotech Ltd.
    Inventor: Abd. Al-Roof Higazi
  • Patent number: 7271144
    Abstract: The invention relates to peptides having the general formula (I), or a salt or amide thereof, wherein R1 and R2 are either the same or different, wherein R1 and R2 are each selected from the group consisting of hydrogen and a saturated or unsaturated hydrocarbon residue, said residue having from 1 to 10 carbon atoms, wherein Z1 is selected from the group consisting of histidine and proline, wherein Z2 is selected from the group consisting of an arginine and a peptide comprising an initial arginine and having from 2 to 30 amino acids.
    Type: Grant
    Filed: June 11, 2003
    Date of Patent: September 18, 2007
    Assignee: Fibrex Medical Research & Development GmbH
    Inventor: Peter Petzelbauer
  • Patent number: 7271145
    Abstract: The present invention relates to blood products, and more particularly to compositions comprising a modified hemoglobin in plasma.
    Type: Grant
    Filed: January 10, 2003
    Date of Patent: September 18, 2007
    Assignee: Sangart, Inc.
    Inventors: Robert M. Winslow, Kim D. Vandegriff
  • Patent number: 7271146
    Abstract: The present invention relates to methods for treating pathological conditions associated with Helicobacter sp infections, specifically H. pylori infection. The present invention further relates to methods for treating pathologies characterized by excess gastric acid secretion. The methods of the present invention comprise oral administration of pentagastrin effective locally in the stomach in conjunction with a gastric proton pump inhibitor. It is disclosed herein for the first time that PG administered orally exerts a local effect in the stomach and may be used in combination with a PPI for treating pathological conditions characterized by excess gastric acid secretion and in pathological conditions associated with Helicobacter sp infections.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: September 18, 2007
    Assignee: Vecta Ltd.
    Inventor: Sabina Glozman
  • Patent number: 7271147
    Abstract: By culturing Lysobacter sp. BMK333-48F3 (deposit number of FERM BP-7477), an antibiotic, tripropeptin Z, tripropeptin A, tripropeptin B, tripropeptin C or tripropeptin D represented by the general formula (I): wherein R is 7-methyl-octyl group, 8-methyl-nonyl group, 9-methyl-dodecyl group, 10-methyl-undecyl group or 11-methyl-dodecyl group, is obtained as antibiotics having excellent antibacterial activities against bacteria and having a novel molecular structure. These tripropeptins each have an excellent antibacterial activity against various bacteria and drug-resistant strains thereof, such as methicillin-resistant strains and vancomycin-resistant strains.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: September 18, 2007
    Assignee: Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
    Inventors: Tomio Takeuchi, Hideki Hashizume, Masayuki Igarashi, Hiroshi Naganawa, Masa Hamada
  • Patent number: 7271148
    Abstract: The invention provides a method of decreasing viral replication in cells, the method comprising decreasing levels of functional cellular protease in the cells. The invention further provides a method of treating or preventing a viral infection in a subject, the method comprising administering to the subject an amount of a compound effective to decrease levels of functional cellular protease in the cells of the subject.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: September 18, 2007
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Thomas B. Albrecht, Zhenping Chen
  • Patent number: 7271149
    Abstract: The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the in vivo half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: September 18, 2007
    Assignee: Eli Lilly and Company
    Inventors: Wolfgang Glaesner, Radmila Micanovic, Sheng-Hung Rainbow Tschang
  • Patent number: 7271150
    Abstract: The invention provides a growth hormone (GH) in which amino acids within the regulated secretory pathway (RSP) sorting signal have been mutated as well as a GH in which the three-dimensional conformation of the RSP sorting signal has been altered, and a composition comprising an effective amount of such a GH in an excipient.
    Type: Grant
    Filed: May 14, 2002
    Date of Patent: September 18, 2007
    Assignee: United States of America, Represented by the Secretary, Department of Health and Human Services
    Inventors: Yoke Peng Loh, Niamh Cawley, Bruce J. Baum, Christopher R. Snell
  • Patent number: 7271151
    Abstract: The present invention relates to a novel human protein called phosphatonin, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.
    Type: Grant
    Filed: August 17, 2004
    Date of Patent: September 18, 2007
    Assignee: Acologix, Inc.
    Inventor: Peter Rowe
  • Patent number: 7271152
    Abstract: The present invention relates to compounds that are capable of modulating CD154 mobilization and that are useful for stabilizing the thrombotic process and reducing the activation of cells involved in an inflammatory response. The present invention also relates to methods useful for identifying such compounds. The present invention also relates to the treatment of platelets for transfusion with metalloproteinase inhibitors to treat or prevent inflammation. The present invention also includes compositions and methods to treat injury and disease related to such biological processes.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: September 18, 2007
    Assignee: CBR Institute for Biomedical Research
    Inventors: Lisa Alaimo, Veronica Alves, Patrick Andre, David Phillips, Sri R. Prasad, Denisa D. Wagner
  • Patent number: 7271153
    Abstract: The present invention provides nitrogen-containing heterocyclic derivatives represented by the general formula: wherein X1 and X3 independently represent N or CH; X2 represents N or CR2; X4 represents N or CR3; and with the proviso that one or two of X1, X2, X3 and X4 represent N; R1 represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a lower alkoxy-substituted (lower alkyl) group, a lower alkoxy-substituted (lower alkoxy) group, a lower alkoxy(lower alkoxy)-substituted (lower alkyl) group, a cyclic lower alkyl group, a halo(lower alkyl) group or a group represented by the general formula: HO-A- wherein A represents a lower alkylene group, a lower alkyleneoxy group or a lower alkylenethio group; R2 represents a hydrogen atom, a halogen atom, a lower alkyl group, a cyclic lower alkyl group, a lower alkoxy group, an amino group, a (lower acyl)amino group, a mono(lower alkyl)amino group or a di(lower alkyl)amino group; and R3 represents a hydrogen a
    Type: Grant
    Filed: June 17, 2002
    Date of Patent: September 18, 2007
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Toshihiro Nishimura, Hideki Fujikura, Nobuhiko Fushimi, Kazuya Tatani, Kenji Katsuno, Masayuki Isaji
  • Patent number: 7271154
    Abstract: This invention features a compound of the following formula: wherein T is a transportophore, L is a bond or linker, and C is an antibiotic therapeutic agent, the transportophore is covalently bonded to the antibiotic therapeutic agent via the bond or the linker, and the transportophore is an azithromycin derivative or crown ether derivative.
    Type: Grant
    Filed: February 14, 2003
    Date of Patent: September 18, 2007
    Assignee: Merckle GmbH
    Inventors: Michael Burnet, Jan-Hinrich Guse, Gene Kim
  • Patent number: 7271155
    Abstract: The present invention discloses compounds of formulae I and II, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
    Type: Grant
    Filed: January 3, 2006
    Date of Patent: September 18, 2007
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Ly Tam Phan, Guoqiang Wang, Yanchun Wang, Yulin Peng
  • Patent number: 7271156
    Abstract: The invention relates to immunostimulatory nucleic acid compositions and methods of using the compositions. The T-rich nucleic acids contain poly T sequences and/or have greater than 25% T nucleotide residues. The TG nucleic acids have TG dinucleotides. The C-rich nucleic acids have at least one poly-C region and/ore greater than 50% c nucleotides. These immunostimulatory nucleic acids function in a similar manner to nucleic acids containing CpG motifs. The invention also encompasses preferred CpG nucleic acids.
    Type: Grant
    Filed: December 9, 2002
    Date of Patent: September 18, 2007
    Assignees: University of Iowa Research Foundation, Coley Pharmaceutical GmbH
    Inventors: Arthur M. Krieg, Jörg Vollmer, Christian Schetter
  • Patent number: 7271157
    Abstract: Disclosed is a synthesis suitable for large scale manufacture of novel compounds that are partial and full A1 adenosine receptor agonist having the structure of Formula I: wherein R is optionally substituted phenyl, that are useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: September 18, 2007
    Assignee: CV Therapeutics, Inc.
    Inventors: Elfatih Elzein, Jeff Zablocki
  • Patent number: 7271158
    Abstract: The invention described herein relates to: the use of an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase in the manufacture of a composition for the treatment of acidosis; a method of treatment of rumen acidosis which comprises administration of an effective amount of an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase to a ruminant; a formulation suitable for the treatment of acidosis in an animal which comprises an effective inhibitor of a bacterial ?-amylase and/or ?-glucosidase in admixture with a suitable excipient, diluent or carrier selected with regard to the intended route of administration and standard pharmaceutical/veterinary/farming practice; screening methods useful in the identification of a suitable inhibitor of a bacterial ?-amylase and/or ?-glucosidase for the treatment of acidosis in a ruminant; a process for improving ruminant milk quality and/or quantity which comprises treatment of a ruminant with an effective amount of an inhibitor of bacterial ?-amyla
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: September 18, 2007
    Assignee: Pfizer Inc.
    Inventors: Bernard Joseph Banks, Mark Andrew Haxell, Graham Lunn, Michael Stephen Pacey, Lee Richard Roberts
  • Patent number: 7271159
    Abstract: The present invention provides generally a compound having the following general formula (1): wherein R1 and R2 are independently the same or different and are hydrogen, an alkyl group, an alkenyl group, a benzyl group, an alkynyl group, an alkoxyl group, an aryloxy group, an acyloxy group, a carbonyloxy group, a carbamoyloxy group, a halogen, a hydroxyl group, a nitro group, a cyano group, an azido group, a formyl group, a hydrazino group, an acyl group, an amino group, —SRc, wherein, Rc is hydrogen, an acyl group, an alkyl group, or an aryl group, or R1 and R2 together form a group of the formula —O(CH2)nO— wherein n represents the integer 1 or 2; R3 is H, F, a halogen atom, a nitro group, an amino group, a hydroxyl group, or a cyano group; or R2 and R3 together form a group of the formula —O(CH2)nO— wherein n represents the integer 1 or 2; R4 is H, F, a C1-3 alkyl group, a C2-3 alkenyl group, a C2-3 alkynyl group, or a C1-3 alkoxyl group; R5 is a C1-10 alkyl group, or a propargyl group; and R6, R7 and
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: September 18, 2007
    Assignee: University of Pittsburgh
    Inventors: Dennis P. Curran, Hubert Josien, Bom David
  • Patent number: 7271160
    Abstract: Bifunctional molecules comprising two hsp-binding moieties which bind to hsp90 in the pocket to which ansamycin antibiotics bind connected via a linker are effective for inducing the degradation and/or inhibition of HER-family tyrosine kinases. For example, a compound of two geldanamycin moities joined by a four-carbon linker provides selective degradation of HER-family tyrosine kinases, without substantially affecting other kinases. These compounds can be used for treatment of HER-positive cancers with reduced toxicity, since these compounds potently kill cancer cells but affect fewer proteins than geldanamycin.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: September 18, 2007
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Neal Rosen, Scott D. Kuduk, Samuel J. Danishefsky, Furzhong F. Zheng, Laura Sepp-Lorenzino, Ouatek Ouerfelli